Investigating protective factors against cognitive decline in centenarians

Protective factors and mechanisms

NIH-funded research Boston University Medical Campus · NIH-10907582

This study is looking at why some people who live to be 100 years old stay sharp and clear-minded, even as they age, and it hopes to find clues that could help develop new treatments for memory problems and Alzheimer's disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBoston University Medical Campus NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-10907582 on NIH RePORTER

What this research studies

This research focuses on understanding why some centenarians maintain cognitive function despite aging, which is a major risk factor for dementia. The project aims to identify genetic and biological mechanisms that contribute to this resilience. It employs a combination of genetic studies, transcriptomic analyses, and advanced 3D brain cell models to explore these protective factors. By studying both centenarians and their offspring, the research seeks to uncover insights that could lead to new treatments for cognitive impairment and Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research include centenarians and their offspring who are cognitively intact or exhibit resilience against cognitive decline.

Not a fit: Patients with advanced Alzheimer's disease or significant cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cognitive decline and Alzheimer's disease.

How similar studies have performed: Other research has shown promise in identifying protective factors in aging populations, making this approach both relevant and potentially impactful.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease model
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.